Nick H Ogden1, Aamir Fazil1, Julien Arino2, Philippe Berthiaume1, David N Fisman3, Amy L Greer4, Antoinette Ludwig1, Victoria Ng1, Ashleigh R Tuite3, Patricia Turgeon1, Lisa A Waddell1, Jianhong Wu5,6. 1. Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, St. Hyacinthe, QC and Guelph, ON. 2. Department of Mathematics & Data Science NEXUS, University of Manitoba, Winnipeg, MB. 3. Dalla Lana School of Public Health, University of Toronto, Toronto, ON. 4. Department of Population Medicine, University of Guelph, Guelph, ON. 5. Laboratory for Industrial and Applied Mathematics, Department of Mathematics and Statistics, York University, Toronto, ON. 6. Fields-CQAM Laboratory of Mathematics for Public Health, York University, Toronto, ON.
Abstract
BACKGROUND: Severe acute respiratory syndrome virus 2 (SARS-CoV-2), likely a bat-origin coronavirus, spilled over from wildlife to humans in China in late 2019, manifesting as a respiratory disease. Coronavirus disease 2019 (COVID-19) spread initially within China and then globally, resulting in a pandemic. OBJECTIVE: This article describes predictive modelling of COVID-19 in general, and efforts within the Public Health Agency of Canada to model the effects of non-pharmaceutical interventions (NPIs) on transmission of SARS-CoV-2 in the Canadian population to support public health decisions. METHODS: The broad objectives of two modelling approaches, 1) an agent-based model and 2) a deterministic compartmental model, are described and a synopsis of studies is illustrated using a model developed in Analytica 5.3 software. RESULTS: Without intervention, more than 70% of the Canadian population may become infected. Non-pharmaceutical interventions, applied with an intensity insufficient to cause the epidemic to die out, reduce the attack rate to 50% or less, and the epidemic is longer with a lower peak. If NPIs are lifted early, the epidemic may rebound, resulting in high percentages (more than 70%) of the population affected. If NPIs are applied with intensity high enough to cause the epidemic to die out, the attack rate can be reduced to between 1% and 25% of the population. CONCLUSION: Applying NPIs with intensity high enough to cause the epidemic to die out would seem to be the preferred choice. Lifting disruptive NPIs such as shut-downs must be accompanied by enhancements to other NPIs to prevent new introductions and to identify and control any new transmission chains.
BACKGROUND: Severe acute respiratory syndrome virus 2 (SARS-CoV-2), likely a bat-origin coronavirus, spilled over from wildlife to humans in China in late 2019, manifesting as a respiratory disease. Coronavirus disease 2019 (COVID-19) spread initially within China and then globally, resulting in a pandemic. OBJECTIVE: This article describes predictive modelling of COVID-19 in general, and efforts within the Public Health Agency of Canada to model the effects of non-pharmaceutical interventions (NPIs) on transmission of SARS-CoV-2 in the Canadian population to support public health decisions. METHODS: The broad objectives of two modelling approaches, 1) an agent-based model and 2) a deterministic compartmental model, are described and a synopsis of studies is illustrated using a model developed in Analytica 5.3 software. RESULTS: Without intervention, more than 70% of the Canadian population may become infected. Non-pharmaceutical interventions, applied with an intensity insufficient to cause the epidemic to die out, reduce the attack rate to 50% or less, and the epidemic is longer with a lower peak. If NPIs are lifted early, the epidemic may rebound, resulting in high percentages (more than 70%) of the population affected. If NPIs are applied with intensity high enough to cause the epidemic to die out, the attack rate can be reduced to between 1% and 25% of the population. CONCLUSION: Applying NPIs with intensity high enough to cause the epidemic to die out would seem to be the preferred choice. Lifting disruptive NPIs such as shut-downs must be accompanied by enhancements to other NPIs to prevent new introductions and to identify and control any new transmission chains.
Authors: Mehdi Najafi; Marek Laskowski; Pieter T de Boer; Evelyn Williams; Ayman Chit; Seyed M Moghadas Journal: Med Decis Making Date: 2017-05-24 Impact factor: 2.583
Authors: Robert Verity; Lucy C Okell; Ilaria Dorigatti; Peter Winskill; Charles Whittaker; Natsuko Imai; Gina Cuomo-Dannenburg; Hayley Thompson; Patrick G T Walker; Han Fu; Amy Dighe; Jamie T Griffin; Marc Baguelin; Sangeeta Bhatia; Adhiratha Boonyasiri; Anne Cori; Zulma Cucunubá; Rich FitzJohn; Katy Gaythorpe; Will Green; Arran Hamlet; Wes Hinsley; Daniel Laydon; Gemma Nedjati-Gilani; Steven Riley; Sabine van Elsland; Erik Volz; Haowei Wang; Yuanrong Wang; Xiaoyue Xi; Christl A Donnelly; Azra C Ghani; Neil M Ferguson Journal: Lancet Infect Dis Date: 2020-03-30 Impact factor: 25.071
Authors: Wycliffe E Wei; Zongbin Li; Calvin J Chiew; Sarah E Yong; Matthias P Toh; Vernon J Lee Journal: MMWR Morb Mortal Wkly Rep Date: 2020-04-10 Impact factor: 17.586
Authors: Adam J Kucharski; Timothy W Russell; Charlie Diamond; Yang Liu; John Edmunds; Sebastian Funk; Rosalind M Eggo Journal: Lancet Infect Dis Date: 2020-03-11 Impact factor: 25.071
Authors: Joel Hellewell; Sam Abbott; Amy Gimma; Nikos I Bosse; Christopher I Jarvis; Timothy W Russell; James D Munday; Adam J Kucharski; W John Edmunds; Sebastian Funk; Rosalind M Eggo Journal: Lancet Glob Health Date: 2020-02-28 Impact factor: 26.763
Authors: László Róbert Kolozsvári; Tamás Bérczes; András Hajdu; Rudolf Gesztelyi; Attila Tiba; Imre Varga; Ala'a B Al-Tammemi; Gergő József Szőllősi; Szilvia Harsányi; Szabolcs Garbóczy; Judit Zsuga Journal: Inform Med Unlocked Date: 2021-08-08
Authors: Jeanna Parsons Leigh; Laryssa G Kemp; Chloe de Grood; Rebecca Brundin-Mather; Henry T Stelfox; Josh S Ng-Kamstra; Kirsten M Fiest Journal: BMC Health Serv Res Date: 2021-04-22 Impact factor: 2.655